New York, NY, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Automated Autoinjectors Market by Design (Customized Autoinjector and Standardized Autoinjector), by Usage (Reusable Autoinjector and Disposable Autoinjector), by Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Others), and by End-User (Hospitals & Clinics and Home Care Settings): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025”. According to the report, the global automated autoinjectors market was valued at approximately USD 4.6 billion in 2018 and is expected to generate around USD 18.19 billion by 2025, at a CAGR of around 21.7% between 2019 and 2025.

Automated autoinjectors are needle-based medical devices used for the administration of fixed dose for specific drug doses. It is used for self-administration by untrained personnel or patients, as it is easy to handle. Furthermore, these devices are used for various allergic reactions, such as wheezing, trouble in breathing, stomach pain, nausea, dizziness, swelling on face, lips, mouth, and tongue and skin allergies, like hives, itching, flushing, etc. Furthermore, the administration site depends on the nature of the drug. For example, insulin shots are injected in the abdomen for quick action. Automated autoinjectors are easy to use and have various advantages, such as reduced needle phobia anxiety, lowered chances of needlestick injuries, better efficacy, and consistent dose accuracy, which, in turn, are likely to propel the automated autoinjectors market globally in the future.

Browse through 71 Tables & 31 Figures spread over 110 Pages and in-depth TOC on “Global Automated Autoinjectors Market: By Product Type, Size, Share, Industry Applications, Segments, Analysis and Forecast 2018–2025”.

Request Free Sample Report of Global Automated Autoinjectors Market Report @ https://www.zionmarketresearch.com/sample/automated-autoinjectors-market

The automated autoinjectors market is divided on the basis of design, application, usage, and end-user. By design, the automated autoinjectors market is includes customized autoinjector and standardized autoinjector. Customized autoinjectors held the largest market share in 2018 in terms of revenue. The standardized autoinjectors are likely to grow rapidly in the future.

By usage, the market is segmented into reusable autoinjector and disposable autoinjector. Reusable autoinjectors held the largest market share in 2018 in terms of revenue, due to their cost-effectiveness and multi-use nature. Furthermore, disposable autoinjectors are intended for better handling and are more popular along with offering enhanced safety features, making it them a preferable option. Thus, this segment is likely to register a high CAGR over the forecast timeline.

Download Free Report PDF Brochure: https://www.zionmarketresearch.com/requestbrochure/automated-autoinjectors-market

The application segment includes anaphylaxis, rheumatoid arthritis, multiple sclerosis, diabetes, and others. Rheumatoid arthritis held a significant share in the market in 2018, owing to the rising prevalence of rheumatoid arthritis (RA). According to Sanofi, more than 400,000 people in the UK suffered from RA in 2017. This number is likely to increase further in the upcoming years. 

By end-user, the market is segmented into hospitals and clinics and home care settings. Home care settings held a major market share of the market in 2018, due to the ease in monitoring and operation of these devices to deliver early emergency care at affordable rates, as these are designed with a user-centric approach in reducing user-associated risk.

Browse the full “Automated Autoinjectors Market by Design (Customized Autoinjector and Standardized Autoinjector), by Usage (Reusable Autoinjector and Disposable Autoinjector), by Application (Anaphylaxis, Rheumatoid Arthritis, Multiple Sclerosis, Diabetes, and Others), and by End-User (Hospitals & Clinics and Home Care Settings): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025” Report at https://www.zionmarketresearch.com/report/automated-autoinjectors-market

North America and Europe held major shares of the global automated autoinjectors market in 2018. Rising chronic diseases, favorable reimbursement policies, and regulatory approvals in the U.S. are likely to drive the North American automated autoinjectors market in the future. As per the RAND Corporation, in 2014, nearly 62% of Americans were affected by chronic diseases. The U.S. has a large population base suffering from multiple chronic conditions and the patient population base are projected to spend more on healthcare, thereby steering the  North American automated autoinjectors market over the estimated timeframe. The European automated autoinjectors market is anticipated to grow rapidly in the upcoming years, due to the growing number of adrenaline autoinjectors (AAI) prescriptions and rising incidences of anaphylaxis. The anaphylaxis incidence rate in the UK is growing rapidly since 2012 based on the stats provided by the NCBI. Additionally, AAI prescription per child is accelerating, which, in turn, is expected to further boost the European automated autoinjectors market in the years ahead.

The Asia Pacific automated autoinjectors market is projected to witness rapid growth in the next few years. Growing awareness about the availability of various treatments, huge population base, increasing patient inflow, and rising healthcare expenditure are likely to propel this regional market in the future. Additionally, government and venture capital investments in China and India and strategies used by major companies to increase revenue and expand their businesses are projected to further fuel the Asia Pacific automated autoinjectors market in the years ahead.

Inquire more about this report before purchase @ https://www.zionmarketresearch.com/inquiry/automated-autoinjectors-market

Latin America and the Middle East and Africa are likely to show a sluggish rate of growth in this market in the future, owing to the availability of new opportunities and funds provided by government to the companies and manufacturers for developing new products and conduct research activities for improved patient healthcare, particularly in Brazil, Mexico, and South Africa.

Some leading players of the global automated autoinjectors market include Unilife Corporation, Becton, Dickinson & Co., Biogen Idec, Pfizer, Inc., Mylan N.V., Sanofi, Owen Mumford, Teva Pharmaceutical, Amgen, Ypsomed, AbbVie, and Scandinavian Health Ltd.

Request customized copy of report @ https://www.zionmarketresearch.com/custom/3849

This report segments the global automated autoinjectors market into:

Global Automated Autoinjectors Market: Design Analysis

Global Automated Autoinjectors Market: Usage Analysis

Global Automated Autoinjectors Market: Application Analysis

Global Automated Autoinjectors Market: End-User Analysis

Global Automated Autoinjectors Market: Regional Analysis

Related Reports:

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Follow Us LinkedIn: https://www.linkedin.com/company/zion-market-research
Follow Us Twitter: https://twitter.com/zion_research

Contact Us:

Joel John
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com

Website: https://www.zionmarketresearch.com

Blog: http://zmrblog.com